JSM 2015 Online Program

Online Program Home
My Program

Legend: Washington State Convention Center = CC, Sheraton Seattle = S, Grand Hyatt = GH and The Conference Center = TCC
* = applied session       ! = JSM meeting theme

Activity Details

191 Mon, 8/10/2015, 10:30 AM - 12:20 PM CC-310
Biomarkers and Endpoint Validation II — Contributed Papers
Biopharmaceutical Section , Biometrics Section
Chair(s): Feng Gao, Takeda Pharmaceuticals
10:35 AM A Proposed Study Design for QT Assessment Using Exposure-Response Modeling Fang Liu, Merck ; Devan Mehrotra, Merck ; Deborah Panebianco, Merck ; Kuenhi Tsai, Merck
10:50 AM Comparison of Missing Data Imputation Methods and Statistical Analysis Methods by Simulation Wenqing Li ; Yun Chon, Amgen ; Yi Wang, Amgen
11:05 AM Early Stopping for Futility or Efficacy in Group-Sequential Clinical Trials with Multiple Co-Primary Endpoints Koko Asakura, National Cerebral and Cardiovascular Center ; Toshimitsu Hamasaki, National Cerebral and Cardiovascular Center ; Scott R. Evans, Harvard University
11:20 AM Design and Analysis of Clinical Trials with Biologics Using Dose Time Response Models Markus Reiner Lange, Novartis Pharma AG ; Heinz Schmidli, Novartis Pharma AG
11:35 AM Using Software to Search for Optimal Cross-Over Designs Byron Jones, Novartis Pharma AG
11:50 AM The Effect of Measurement Error on Biomarker Adaptive Threshold Design Hong Tian, Janssen Research and Development ; Kevin Liu, Janssen R&D
12:05 PM Estimating Adverse Event Rate Differences Using Data from Blinded Trials: The Canary in the Coal Mine A. Lawrence Gould, Merck Research Laboratories ; William W.B. Wang, Merck Research Laboratories

For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home